Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer

Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer

Bibliographic Details
Main Authors: Li, Yuqing, Li, Yi, Wedrén, Sara, Li, Guoliang, Charn, Tze Howe, Desai, Kartiki Vasant, Bonnard, Carine, Czene, Kamila, Humphreys, Keith, Darabi, Hatef, Einarsdóttir, Kristjana, Heikkinen, Tuomas, Aittomäki, Kristiina, Blomqvist, Carl, Chia, Kee Seng, Nevanlinna, Heli, Hall, Per, Liu, Edison T, Liu, Jianjun
Format: Online
Language:English
Published: BioMed Central 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109578/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109578/

Similar Items